| Serial Number | 87931502 |
| Word Mark | LECONVIN |
| Filing Date | Tuesday, May 22, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 12, 2019 |
| Registration Number | 5909234 |
| Registration Date | Tuesday, November 12, 2019 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 29, 2019 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of designed capital letters "LECONVIN" with letter "L" resembling two leaves. |
| Goods and Services | Tonics of medicines, namely, medicinal tea; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, rhinitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemical-pharmaceutical preparations for tumor-suppression and antiviral treatment; Injectable syringes sold filled with vaccines, antivirals and tumor-suppression agents; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctures in the nature of medicinal herb extracts; Tincture of iodine; Tinctures in the nature of antiseptics for use in the treatment of traumatic injuries; Herbs for medicinal purposes; Nutritional supplements; Dietetic foods, namely, dietetic crackers, dietetic sugar for medical use, Dietetic sugar substitutes for medical use; Dietary and nutritional supplements; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Nutraceuticals for use as a dietary supplement; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels |
| Goods and Services | Beer; Water beverages; Non-alcoholic malt beverages; Non-alcoholic beverages containing fruit juices; Non-alcoholic water-based beverages; Aerated water; Non-alcoholic beverages flavored with tea; Vegetable drink; Preparations for making beverages, namely, fruit drinks; Syrups for beverages; Concentrates and powders used in the preparation of energy drinks and fruit-flavored beverages; Energy drinks; Energy drinks enhanced with vitamins, minerals, nutrients; Isotonic beverages; Isotonic drinks; Isotonic non-alcoholic drinks; Powders used in the preparation of isotonic sports drinks and sports beverages; Protein-enriched sports beverages; Sports drinks; Sports drinks enhanced with vitamins, minerals, nutrients; Sports drinks, namely, energy drinks; Sports drinks, namely, performance drinks; Whey beverages |
| Translation of Words in Mark | The wording "LECONVIN" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 31, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, June 20, 2019 |
| First Use In Commerce Date | Thursday, June 20, 2019 |
| International Class | 032 - Beers; mineral and aerated waters and other nonalcoholic drinks; fruit drinks and fruit juices; syrups and other preparations for making beverages. |
| US Class Codes | 045, 046, 048 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, May 31, 2018 |
| Primary Code | 032 |
| First Use Anywhere Date | Thursday, June 20, 2019 |
| First Use In Commerce Date | Thursday, June 20, 2019 |
| Party Name | Medoncare Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Changsha, Hunan Prov. 410205 CN |
| Party Name | Medoncare Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Changsha, Hunan Prov. 410205 CN |
| Party Name | Medoncare Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Changsha, Hunan Prov. 410205 CN |
| Event Date | Event Description |
| Tuesday, November 12, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, October 8, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Monday, October 7, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, October 5, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, September 17, 2019 | USE AMENDMENT FILED |
| Saturday, October 5, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, September 17, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, March 26, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 29, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 29, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 9, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, December 22, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 21, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 21, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 21, 2018 | ASSIGNED TO LIE |
| Tuesday, December 18, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 17, 2018 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, July 17, 2018 | PRIORITY ACTION E-MAILED |
| Tuesday, July 17, 2018 | PRIORITY ACTION WRITTEN |
| Friday, July 13, 2018 | ASSIGNED TO EXAMINER |
| Friday, June 1, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, May 31, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, May 25, 2018 | NEW APPLICATION ENTERED IN TRAM |